UDP-GalNAc:beta-1,3-N-acetylgalactosaminyltransferase 1

Summary
UniProt ID
O75752
Gene Symbol
  • B3GALNT1
  • B3GALT3
Organism
Homo sapiens (human)
External Links
GlycoProtDB
GPDB0011248
GlyGen
O75752
PubChem
O75752
SwissLipids
The Human Metabolome Database
HMDBP01054
Annotation
Keyword
  • Blood group antigen
  • Glycoprotein
  • Glycosyltransferase
  • Golgi apparatus
  • Lipid metabolism
  • Magnesium
  • Reference proteome
  • Signal-anchor
  • Transmembrane helix
Gene Ontology (GO)
Sequence
MASALWTVLPSRMSLRSLKWSLLLLSLLSFFVMWYLSLPHYNVIERVNWMYFYEYEPIYRQDFHFTLREHSNCSHQNPFLVILVTSHPSDVKARQAIRVTWGEKKSWWGYEVLTFFLLGQEAEKEDKMLALSLEDEHLLYGDIIRQDFLDTYNNLTLKTIMAFRWVTEFCPNAKYVMKTDTDVFINTGNLVKYLLNLNHSEKFFTGYPLIDNYSYRGFYQKTHISYQEYPFKVFPPYCSGLGYIMSRDLVPRIYEMMGHVKPIKFEDVYVGICLNLLKVNIHIPEDTNLFFLYRIHLDVCQLRRVIAAHGFSSKEIITFWQVMLRNTTCHY
Glycosylation Sites
Displaying all 9 entries
Position Description PubMed ID GlyTouCan ID Source
72 N-linked (GlcNAc...) asparagine
153
154 N-linked (GlcNAc...) asparagine
198 N-linked (GlcNAc...) asparagine
212 N-linked (GlcNAc...) asparagine
222
225
226
326 N-linked (GlcNAc...) asparagine
Feature
  • ProtVista GlyGen : Glycosylation Site from GlyGen
  • ProtVista UniProt : Glycosylation Site from UniProt
Pathway
Displaying 1 entry
Pathway Name Organism
Glycosphingolipid biosynthesis Homo sapiens
Disease
Displaying all 5 entries
DO ID Disease Name Source
DOID:1319 brain cancer
DOID:1324 lung cancer
DOID:162 cancer
DOID:3498 pancreatic ductal adenocarcinoma
DOID:3908 lung non-small cell carcinoma

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024